Confidential To FDA Staff: Torti Memo Warns Employees About Confidential Info
This article was originally published in The Pink Sheet Daily
Items that must be kept under wraps include trade secrets and privileged intra-agency documents, acting commissioner says.
You may also be interested in...
Details trickling into the public sphere about CDRH's device review process reveal heightened tension between reviewers and management over the proper response to a 510(k) submission
Recent improvements to FDA's screening process for intellectual conflicts of interest among advisory committee members are likely to be part of the agency's response to a congressional inquiry into the review of Lilly's prasugrel (Effient)
Some believe unmet need refers only to rare diseases and tiny patient populations. But it is more than this. In 2020, the term sits at the heart of decision-making for drug makers – along with cost, access and value, of course.